You are here

Article Text

Article menu
Download PDFPDF
Miscellanea
Journal club
Linezolid for XDR-TB
  1. Richard D Turner
  1. Correspondence to Dr Richard Turner, Department of Respiratory Medicine, Homerton University Hospital NHS Foundation Trust, Homerton Row, London E9 6SR, UK; richard.turner{at}homerton.nhs.uk

https://doi.org/10.1136/thoraxjnl-2013-203399

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    This randomised phase 2a trial in South Korea recruited 41 patients with sputum culture-positive pulmonary extensively drug-resistant tuberculosis (XDR-TB), who had failed to respond to 6 months of available treatment. Daily dosage of 600 mg linezolid was added either immediately or after a delay of two months. After four months of linezolid, or two consecutive …

    View Full Text